Figure 4.
Levels of proMMP‐2 and proMMP‐9 in serum samples from healthy and COPD smokers. Representative gelatin zymograms of two samples from each group are shown. Controls include (a) proMMP‐9 and proMMP‐9/NGAL, and (b) proMMP‐2/MMP‐9 and active MMP‐2/MMP‐9. Expression profiles of proMMP‐2/MMP‐9 and the proMMP‐9/NGAL complex in sera (5 μl) for healthy smokers and COPD smokers (GOLD I‐IV).